Kim K, Amonkar MM, H ögberg D, Kasteng F. Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK. Head Neck Oncol. 2011 Oct 28;3:47.
Conclusions
In the UK, SCCHN patients after surgical resection needed considerable healthcare resources and incurred substantial costs. Study findings might provide a useful source for clinicians and decision makers in understanding the economic burden of managing SCCHN in the UK and also sugge sts a need for new therapies that could improve outcomes and reduce the disease burden. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Wiskirska-Wo & #378;nica B, Leszczy & #324;ska M, Swidzi & #324;ski, Czerniejewska H, Jackowska J, Witold S. Voice estimation in patients after reconstructive subtotal laryngectomy. Head Neck Oncol. 2011 Oct 26;3:46.
Conclusions
The perceptual voice estimation revealed a good phonation result in only 3 cases after using surgery with the Calearo method as well as the best results of MPT. The VHI reflected severe voice handicap in 2 patients (26 to 40 poin ts). No statistically significant differences were observed between the values of the acoustic parameters in MDVP analysis after following operation -CHEP, Calearo, Sedlacek. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Cordella C, Luebbers HT, Rivelli V, Gr ätz KW, Kruse AL. An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol. 2011 Aug 15;3:35.
Conclusion
Our data suggests that an Hb of below 11 g/dl contributes to and is an indicator for a poor prognosis. Consequently, pre-treatment Hb corrections may significantly improve outcome, but further investigations, including blood transfusion/application of erythropoietin due to tumor anem ia, independent of intraoperative blood-loss are necessary to ascertain their role in an improved survival. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Eckardt AM, Kokem üller H, Tavassol F, Gellrich NC. Reconstruction of oral mucosal defects using the nasolabial flap: clinical experience with 22 patients. Head Neck Oncol. 2011 May 23;3:28.
Conclusions
The nasolabial flap is a valuable alternative for reconstruction of smaller defects of the oral cavity in particular in older and medically compromised patients. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Schwager K, Villa A, R ösli C, Neri D, Rösli-Khabas M, Moser G. A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer. Head Neck Oncol. 2011 May 8;3:25.
Conclusions
These results suggests that an individualized treatment procedure (e.g., choice of L19, F8 or F 16 based on immuno-PET or immunofluorescence procedure) may represent the most logical avenue for offering the best possible antibody to any given patient. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Rana M, Warraich R, Kokem üller H, Lemound J, Essig H, Tavassol F, Eckardt A, Gellrich NC. Reconstruction of mandibular defects - clinical retrospective research over a 10-year period -. Head Neck Oncol. 2011 Apr 28;3:23.
Conclusion
Based on this study, autogenous bone grafts are a reliable treatment modality for the reconstruction of mandibular bone defects with predic table aesthetic and functional outcomes. As the free vascularized fibular flap has the least resorption and failure rate, it should be the first choice for most cases of mandiblular reconstruction. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Moser S, Beer M, Damerau G, L übbers HT, Grätz KW, Kruse AL. A case report of metastasis of malignant mesothelioma to the oral gingiva. Head Neck Oncol. 2011 Apr 22;3:21.
Conclusion
This article highlights the importance of biopsy and histopathological diagnosis of oral lesions especially in case of a malignant history. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Peltonen JK, V ähäkangas KH, Helppi HM, Bloigu R, Pääkkö P, Turpeenniemi-Hujanen T. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study. Head Neck Oncol. 2011 Apr 22;3:20.
Conclusions
These data indicate that a TP53 mutation in L2, L3 or LSH is worth pursuing as a marker for predicting prognosis and response to radiation among HNSCC patients. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Rivelli V, Luebbers HT, Weber FE, Cordella C, Gr ätz KW, Kruse AL. Screening recurrence and lymph node metastases in head and neck cancer: the role of computer tomography in follow-up. Head Neck Oncol. 2011 Mar 25;3:18.
Conclusion
Routine CT for follow-up is still indicated for detecting lymph node metastases as well as local recurrence. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Kom ínek P, Stárek I, Geierová M, Matouek P, Zeleník K. Phosphaturic mesenchymal tumour of the sinonasal area: case report and review of the literature. Head Neck Oncol. 2011 Mar 16;3:16.
Conclusion
PMT is rare in the sinonasal region, it can be rarely observed without the signs of osteomalacia. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Kruse AL, Luebbers HT, Gr ätz KW. Evaluation of white blood cell count as a possible prognostic marker for oral cancer. Head Neck Oncol. 2011 Feb 27;3:13.
Conclusion
In conclusion, our findings demonstrate that elevated WBC count does not seem to be a predictor fo r recurrence or for further metastases. Further research is recommended to investigate the WBC count in precancerous lesions and in HPV positive patients with oral SCC. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Kruse AL, Luebbers HT, Obwegeser JA, Bredell M, Gr ätz KW. Evaluation of the pectoralis major flap for reconstructive head and neck surgery. Head Neck Oncol. 2011 Feb 27;3:12.
Conclusion
The PMMF is a flap for huge defects in head and neck reconstructive surgery, in particular when a bulky flap is needed in order to cover the carotid artery or reconstructive surgery, but the complication rate should not be underestimated in particular after radiotherapy. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Tavassol F, Starke OF, Kokem üller H, Wegener G, Müller-Tavassol CC, Gellrich NC, Eckardt A. Prognostic significance of heat shock protein 70 (HSP70) in patients with oral cancer. Head Neck Oncol. 2011 Feb 23;3:10.
Conclusions
The survival of patients suffering from T2 tumors with positive HSP70 expression was 8 times higher than that for patients with negative HSP70 expression, suggesting that T1-T2 tumors of OSCC with low expression of HSP70 require more radical treatment. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
St Guily JL, Clavel C, Oka ïs C, Prétet JL, Beby-Defaux A, Agius G, Birembaut P, Jacquard AC, Léocmach Y, Soubeyrand B, Riethmuller D, Denis F, Mougin C. Human papillomavirus genotype distribution in tonsil cancers. Head Neck Oncol. 2011 Feb 7;3(1):6.
Conclusions
Our results indicate that HPV is common in tonsil carcinomas and emphasize the predominant role of HPV 16. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
Silveira AP, Gon çalves J, Sequeira T, Ribeiro C, Lopes C, Monteiro E,Pimentel FL. Geriatric oncology: comparing health related quality of life in head and neck cancer patients. Head Neck Oncol. 2011 Jan 13;3:3.
Conclusions
Geriatric oncology assessments signalize age-independent indicators t hat might guide oncologic geriatric care optimization. Decision-making in geriatric oncology must be based on tumour characteristics and chronological age but also on performance status evaluation, co-morbidity, and patient reported outcomes assessment. (Source: Head and Neck Oncology)
Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research
